Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
CH0013841017
Tue, 27.05.2025
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
The One Lonza organizational structure became effective on 1 April 2025 and comprises three CDMO Business Platforms: Integrated Biologics, Advanced Synthesis and Specialized Modalities
Lonza reports 2024 financials for the CDMO Business Platforms for sales, CORE EBITDA, CORE EBITDA margin and CapEx for th [ … ]
Fri, 09.05.2025
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Strong CDMO1 performance in Q1 2025, in line with expectations for FY 2025
Robust commercial demand in CDMO business with high utilization in early-stage business, Bioscience returning to growth
Tangible recovery and good momentum in Capsules & Health Ingredients (CHI) as expected
CDMO Outlook 2025 [ … ]
Thu, 03.04.2025
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Annual General Meeting will take place on 9 May 2025 at the Congress Center in Basel, Switzerland
Jean-Marc Huët proposed for re-election as Chair of the Board of Directors
All current Board Members with the exception of Olivier Verscheure are standing for re-election
Three candidates (Juan Andres, Eric [ … ]
Wed, 29.01.2025
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
In 2024, Lonza delivered sales of CHF 6.6 billion in line with prior year (-0.2% CER1)
CORE EBITDA of CHF 1.9 billion at a margin of 29.0%
The CDMO2 business delivered a strong commercial and operational performance, while Capsules & Health Ingredients (CHI) experienced market headwinds
The propose [ … ]